ToxSci Advance Access originally published online on May 19, 2006
Toxicological Sciences 2006 92(2):456-463; doi:10.1093/toxsci/kfl020
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The Interaction of Manganese Nanoparticles with PC-12 Cells Induces Dopamine Depletion



* Applied Biotechnology Branch, Human Effectiveness Directorate, Air Force Research Laboratory, Wright-Patterson AFB, Ohio 45431;
Department of Chemical and Materials Engineering, University of Dayton, Dayton, Ohio 45469; and
Neurochemistry Laboratory, Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, Arkansas 72079
Received February 5, 2006; accepted March 25, 2006
This investigation was designed to determine whether nano-sized manganese oxide (Mn-40nm) particles would induce dopamine (DA) depletion in a cultured neuronal phenotype, PC-12 cells, similar to free ionic manganese (Mn2+). Cells were exposed to Mn-40nm, Mn2+ (acetate), or known cytotoxic silver nanoparticles (Ag-15nm) for 24 h. Phase-contrast microscopy studies show that Mn-40nm or Mn2+ exposure did not greatly change morphology of PC-12 cells. However, Ag-15nm and AgNO3 produce cell shrinkage and irregular membrane borders compared to control cells. Further microscopic studies at higher resolution demonstrated that Mn-40nm nanoparticles and agglomerates were effectively internalized by PC-12 cells. Mitochondrial reduction activity, a sensitive measure of particle and metal cytotoxicity, showed only moderate toxicity for Mn-40nm compared to similar Ag-15nm and Mn2+ doses. Mn-40nm and Mn2+ dose dependently depleted DA and its metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), while Ag-15nm only significantly reduced DA and DOPAC at concentrations of 50 µg/ml. Therefore, the DA depletion of Mn-40nm was most similar to Mn2+, which is known to induce concentration-dependent DA depletion. There was a significant increase (> 10-fold) in reactive oxygen species (ROS) with Mn-40nm exposure, suggesting that increased ROS levels may participate in DA depletion. These results clearly demonstrate that nanoscale manganese can deplete DA, DOPAC, and HVA in a dose-dependent manner. Further study is required to evaluate the specific intracellular distribution of Mn-40nm nanoparticles, metal dissolution rates in cells and cellular matrices, if DA depletion is induced in vivo, and the propensity of Mn nanoparticles to cross the blood-brain barrier or be selectively uptaken by nasal epithelium.
Key Words: nanoparticles; manganese; in vitro toxicity; PC-12 cells; dopamine.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. C. Murdock, L. Braydich-Stolle, A. M. Schrand, J. J. Schlager, and S. M. Hussain Characterization of Nanomaterial Dispersion in Solution Prior to In Vitro Exposure Using Dynamic Light Scattering Technique Toxicol. Sci., February 1, 2008; 101(2): 239 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Stern and S. E. McNeil Nanotechnology Safety Concerns Revisited Toxicol. Sci., January 1, 2008; 101(1): 4 - 21. [Abstract] [Full Text] [PDF] |
||||
